Tower Research Capital (TRC)’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.38K | Sell |
1,832
-392
| -18% | -$937 | ﹤0.01% | 4336 |
|
|
2025
Q1 | $9.56K | Buy |
2,224
+23
| +1% | +$99 | ﹤0.01% | 3758 |
|
|
2024
Q4 | $18.9K | Buy |
2,201
+170
| +8% | +$1.46K | ﹤0.01% | 3227 |
|
|
2024
Q3 | $34.5K | Buy |
2,031
+537
| +36% | +$9.13K | ﹤0.01% | 2931 |
|
|
2024
Q2 | $22.6K | Buy |
1,494
+546
| +58% | +$8.24K | ﹤0.01% | 3684 |
|
|
2024
Q1 | $15.7K | Buy |
948
+270
| +40% | +$4.48K | ﹤0.01% | 3228 |
|
|
2023
Q4 | $10.8K | Buy |
678
+530
| +358% | +$8.47K | ﹤0.01% | 4197 |
|
|
2023
Q3 | $11.3K | Buy |
148
+74
| +100% | +$5.63K | ﹤0.01% | 4011 |
|
|
2023
Q2 | $4.85K | Sell |
74
-174
| -70% | -$11.4K | ﹤0.01% | 4870 |
|
|
2023
Q1 | $15K | Sell |
248
-344
| -58% | -$20.8K | ﹤0.01% | 3834 |
|
|
2022
Q4 | $14K | Buy |
+592
| New | +$14K | ﹤0.01% | 3548 |
|
|
2022
Q3 | – | Sell |
-129
| Closed | -$3K | – | 6570 |
|
|
2022
Q2 | $3K | Sell |
129
-851
| -87% | -$19.8K | ﹤0.01% | 5425 |
|
|
2022
Q1 | $29K | Buy |
980
+856
| +690% | +$25.3K | ﹤0.01% | 3204 |
|
|
2021
Q4 | $11K | Sell |
124
-6
| -5% | -$532 | ﹤0.01% | 4472 |
|
|
2021
Q3 | $10K | Buy |
130
+126
| +3,150% | +$9.69K | ﹤0.01% | 4350 |
|
|
2021
Q2 | $0 | Buy |
+4
| New | – | ﹤0.01% | 5912 |
|